Who we are With around 80 people worldwide, Roche Partnering offers speed, flexibility, accessibility and decision making authority. Roche?s team is highly qualified and covers a diversity of roles: finders, analysts, negotiators, lawyers, due diligence managers, alliance management specialists, information specialists, and communications experts. We have offices in Basel (Switzerland), Nutley (USA), South San Francisco (USA), Tokyo (J), and Shanghai (China).
We look forward to transforming key partnerships into long-term strategic alliances. Success is much more than the deal itself. Real rewards come through partnerships that work in the long run.
What we are looking forRoche searches for partners based on both strategic and cultural fits. We look for product opportunities in our five Disease Biology Areas of oncology, metabolism, CNS, inflammation and virology.
In research and technologies, we actively pursue opportunities in
antibody generation, antibody engineering, intracellular and BBB targeting, Chemical Biology, Stem cell(s) and related technologies, Membrane bound structures, Peptides as tools for target discover & assay development, Peptides as therapeutics, synthetic generation or natural libraries for cell/tissue specific targeting and intractable/difficult targets. Further details and contacts can be found in our brochure
We always look for partners that have a shared vision, strong motivation and an ambitious outlook. Flexibility is important, as is solid management and a capacity for long-term growth. Of course, like our own R&D, creative ideas and scientific rigour are paramount. .PrintBookmarkBookmark to your Favorites publish or share it on: GoogledeliciousdiggFacebookReddItStumbleUponMister WongTwitter Send Your name*This field is required Your e-mail address*This field is requiredEMail not valid Recipient e-mail address* (max 10 adresses with comma separated)This field is requiredEMail not validtoo much EMail Adresses By using the service, you agree to the following: Your email address and the recipient's email address will be used for transmission purposes only - to inform the addressee about the sender, or for sending a message in the event of a transmission error. To avoid misuse of this service, F. Hoffmann-La Roche will save each user's identification data (IP address) for a period of two months. If third parties can demonstrate that their rights have been infringed by the sending of an item using this service, F. Hoffmann-La Roche will hand over the identification data for the purposes of legal action. Send RatePlease rate this page: 12345 Feel free to leave a comment Submit.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)